| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |